Cyclacel Pharmaceuticals - BGMS Quarterly EPS earnings growth

Corporate company logo of Bio Green Med Solution (BGMS)

Bio Green Med Solution Inc's bet on attracting leading oncologists and maintaining a flexible corporate culture has defined its development trajectory. The quarterly EPS growth rate clearly visualizes this process, with the latest figure standing at 93.70. Business revenues are based on the creation of cell cycle inhibitors, while the scaling strategy relies on targeted research alliances with investment funds.

cyclacel.com (BGMS) Year-over-year earnings per one share growth for the last 12 months: for the period 09/13/2025 - 11/15/2026

Analytical breakdowns for Bio Green Med Solution Inc

- share price and consensus valuation forecast:
Stock Quotes Bio Green Med Solution|BGMS - Analyst Forecast Prices
- issuer market value details:
Market Capitalization Cyclacel|BGMS - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Bio Green Med Solution|BGMS - Accounting Value of Company|Market Capitalization to Book Value Ratio cyclacel.com|BGMS - Company Balance Sheet Assets
- debt and liquidity data:
Total Debt to Capital Bio Green Med Solution Inc|BGMS - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Bio Green Med Solution Inc|BGMS - Company Cumulative Indebtedness|Debts to Book Capitalization Cyclacel Pharmaceuticals|BGMS - Long-Term Debt|Company Short-Term Debts Bio Green Med Solution|Quick Liquidity Indicator cyclacel.com
- earnings and market multiples details:
BGMS - Final Profit|Future Profit Bio Green Med Solution Inc|BGMS - Market Price to Net Income Ratio|Forward P/E Multiple Bio Green Med Solution Inc|BGMS - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Cyclacel Pharmaceuticals|BGMS - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Bio Green Med Solution|BGMS - Earnings per share for the trailing year|Quarterly EPS earnings growth cyclacel.com|BGMS - Earnings growth in current year|Net earnings per share growth forecast for next year Bio Green Med Solution Inc
- sales revenue and business income indicators:
BGMS - Company Annual Revenue|Company Future Sales Volume cyclacel.com|BGMS - Price to Sales|Forward P/S Multiple Bio Green Med Solution|BGMS - Sales Growth YoY (Last Twelve Months)
Fundamental company valuation:cyclacel.com - BGMS
Flagship merchandise of cyclacel.com

Analyzing comparable quarterly EPS growth allows for an assessment of the investment attractiveness of Bio Green Med Solution Inc. as a developer of targeted cancer therapy. This indicator measures the dynamics of net income per share, smoothing timing gaps between reports to identify asset revaluation momentum, which confirms the company's financial stability amid costs associated with RSU programs used to retain leading biotechnologists.

Analysis of competing companies

GMAB (Genmab) - Year-over-year net earnings per share growth for the last 12 months|EXEL: Year-over-year earnings per share growth rate for the last twelve months|NUVL (Nuvalent Therapeutics) - Quarterly EPS earnings growth|Quarterly EPS earnings growth kymeratx.com|Year-over-year earnings per share growth for the last twelve months IDEAYA Biosciences, Inc. (IDYA)|ELVN (Enliven Therapeutics, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORIC (ORIC Pharmaceuticals Inc)|Net earnings per share growth for the trailing year Relay Pharma|Nurix Therapeutics Inc - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Tyra Biosciences|VSTM (Verastem, Inc.) - Year-over-year net earnings per share growth for the last 12 months|GLUE: Year-over-year earnings per share growth rate for the last twelve months|CGEM (cullinanoncology.com) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Immuneering Inc. IMRX|Quarterly EPS earnings growth CCCC|Black Diamond Therapeutics - Year-over-year earnings per share growth for the last 12 months|Repare Therapeutics Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PMVP|KPTI: Year-over-year net earnings per share growth for the last 12 months|propanc.com - Year-over-year earnings per share growth rate for the last twelve months|AADI: Quarterly EPS earnings growth|Aileron Therapeutics Inc - Year-over-year earnings per one share growth for the last 12 months|BPMC (Blueprint Medicines Corp.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months glycomimetics.com GLYC|Year-over-year earnings per share growth for the last twelve months SpringWorks (SWTX)